[Thyroid cancers].
We have analysed factors that influenced on the patient survival in 195 cases of thyroid cancer. The survival is essentially influenced by the histology, the papillary forms (survival after 15 years: 83.1-93%) and follicular cancers (survival after 15 years: 84-94%) having an excellent evolution. The non-differentiated and mixed cancers have a very severe prognosis that is independent of the complex therapy that have been used (survival after 5 years: 17.1% in non-differentiated forms and 32.5% in mixed ones). The prognosis is better in subjects under the age of 45 and in female subjects. The cancers in the 1-st and 2-nd stage of tumor extension have a better evolution that those in the 3-rd stage. In differentiated cancers, the total or subtotal thyroidectomy followed by radioiodine administration determine the best survival.
Mogoş
V
V
Clinica Endocrinologică, Universitatea de Medicină şi Farmacie Gr. T. Popa, Iaşi.
Zbranca
E
E
Strat
V
V
Diaconescu
M R
MR
Chifan
M
M
Florea
N
N
Costăchescu
G
G
Găleşanu
M R
MR
Rusu
V
V
Georgescu
G
G
D018263:Adenocarcinoma, Follicular / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D000328:Adult; D017677:Age Distribution; D018276:Carcinoma, Medullary / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D002291:Carcinoma, Papillary / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012383:Romania / Q000453:epidemiology; D017678:Sex Distribution; D013964:Thyroid Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D013965:Thyroidectomy / Q000706:statistics & numerical data
Les cancers thyroidiens.